Related Experiment Videos
Follicular dendritic cell sarcoma of lymph node--a rare entity
Safoorah Khalid1, Nausheen Yaqoob, Shahid Pervez
1Department of Pathology and Microbiology, The Aga Khan University, Karachi.
Summary
Follicular dendritic cell (FDC) tumors, rare immune system accessory cells, can occur in lymph nodes and extranodal sites. This case highlights FDC tumor identification using the CD21 marker in lymph node presentation.
Area of Science:
- Immunology
- Oncology
- Pathology
Background:
- Follicular dendritic cells (FDCs) are crucial accessory cells in the immune system, regulating germinal center reactions and antigen presentation.
- FDCs are characterized by specific markers (CD21+, CD35+) and ultrastructural features like desmosomes.
- FDC tumors most commonly arise in lymph nodes but can occur in various extranodal sites.
Observation:
- This study presents a case of a tumor originating in the lymph nodes.
- Histological examination revealed tumor cells with distinct features: abundant eosinophilic cytoplasm, hyperchromatic and pleomorphic nuclei, and prominent nucleoli.
- Immunohistochemical analysis confirmed tumor cell positivity for CD21.
Findings:
- CD21 positivity is a specific diagnostic marker for follicular dendritic cell tumors.
- The observed histological features are consistent with FDC tumor morphology.
- The tumor's location in the lymph nodes aligns with the common presentation of FDC tumors.
Implications:
- Accurate identification of FDC tumors is essential for appropriate diagnosis and management.
- The use of CD21 as a specific marker aids in differentiating FDC tumors from other neoplasms.
- Further case studies and research can improve understanding of FDC tumor behavior and treatment strategies.
